| Gene Set | Leading Edge Genes |
|---|
| KEGG PARKINSONS DISEASE | ATP5C1, VDAC1, PARK7, NDUFA1, NDUFB5, CYC1, NDUFS1, SDHC, ATP5O, NDUFB3, NDUFA9, ATP5G1, ATP5J, COX7A2, COX6C, SDHD |
| KEGG OXIDATIVE PHOSPHORYLATION | NDUFB3, ATP5O, NDUFA9, ATP5I, ATP5C1, ATP5G1, ATP5J, COX7A2, NDUFA1, COX6C, NDUFB5, CYC1, SDHD, NDUFS1, SDHC |
| WONG EMBRYONIC STEM CELL CORE | SQLE, ATP5O, NDUFA9, DLAT, HADH, DBF4, CSE1L, FDPS, NCBP2, BANF1, SDHD, ZNF22, SDHC, LSM2 |
| ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UP | CETN2, PAPSS1, SEC24D, HPRT1, PEA15, GNPAT, NCBP2, NDUFB5, SDHC, NDUFB3, PSMB2, MSH6, METAP1, PDIA6, ACP1, COX7A2, SSR2, SPCS2, ZMPSTE24, TBCE, ACLY, RPA1, CNIH, KDELR2 |
| NCI CITRIC ACID CYCLE TCA CYCLE | SUCLA2, SDHD, SDHC |
| REACTOME CELL CYCLE MITOTIC | PSMB2, PSMD5, PSMC5, CDC16, UBE2D1, CETN2, CDC23, DBF4, PPP2R5C |
| REACTOME CELL CYCLE CHECKPOINTS | PSMB2, PSMD5, PSMC5, CDC16, UBE2D1, CDC23 |
| CORUM CSA COMPLEX | |
| NCI CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | |
| REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | |
| REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | ATP5O, ATP5I, ATP5C1, ATP5G1, ATP5J |
| CAIRO HEPATOBLASTOMA CLASSES UP | |
| REACTOME INACTIVATION OF APC VIA DIRECT INHIBITION OF THE APCOMPLEX | CDC16, UBE2D1, CDC23, ANAPC5 |
| NCI INACTIVATION OF APC C VIA DIRECT INHIBITION OF THE APC C COMPLEX | CDC16, UBE2D1, CDC23, ANAPC5 |
| RHODES CANCER META SIGNATURE | |
| NCI APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | |
| LASTOWSKA NEUROBLASTOMA COPY NUMBER DN | |
| NCI FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | |
| NCI APC CDC20 MEDIATED DEGRADATION OF NEK2A | |
| CORUM CSA-POLIIA COMPLEX | |
| NCI REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE | |
| LINDGREN BLADDER CANCER WITH LOH IN CHR9Q | |
| REACTOME CITRIC ACID CYCLE | |
| REACTOME G2 M CHECKPOINTS | |
| KEGG NUCLEOTIDE EXCISION REPAIR | |